teams - Lavo Protocol

— DR. JAC

Dr. Jac is an MBBS graduate from Shanghai Jiao Tong University School of Medicine with extensive experience in regenerative medicine, anti-aging research, and biotechnology translation. Since 2014, he has collaborated with INFUSIO Germany on Stromal Vascular Stem Cell (SVSC) research, specializing in Lyme disease therapy, regenerative medicine, and anti-aging treatments. Over time, his research focus expanded to exosome science and its translational applications.

In 2019, Dr. Jac co-founded Shanghai Kun Wu Biotechnology Ltd., a Sino-German biotechnology platform dedicated to research in stem cells, cytokines, anti-aging interventions, and chronic disease therapeutics. In 2022, he was appointed Scientific Advisor to the Pearlosophy skincare brand , further bridging scientific research with consumer-facing biotechnology products.

In 2024, he founded Lestari Cosmetics Sdn. Bhd. in Malaysia, where he launched CELL MELODY, an innovative anti-aging skincare brand. Building on his extensive scientific and entrepreneurial experience, Dr. Jac established LAVO LAB in 2025, a dedicated platform focusing on longevity science, exosomes, regenerative medicine, and advanced skincare innovation, driving the development of next-generation biotechnology-grade formulations for global consumers.

— DR. ANTON

(ANTON PHILIP BATTIADE GIACOMO)

Dr. Anton is a British national and a highly respected expert in stem cell and exosome technologies, with over 20 years of experience across biotechnology, integrative medicine, and advanced cosmetic science. He has worked extensively in Germany and the United States, where he previously operated cell therapy clinics and developed deep, hands-on expertise in clinical-grade biotechnology and regenerative research.

Over the past 15 years, Dr. Anton has built and collaborated with an international network of leading physicians and scientists, contributing to the establishment of medical and research hubs across Germany, the United States, Ghana, India, South Africa, and New York. Through this work, he became widely recognized as an international medical consultant, educator, researcher, and expert spokesperson in the fields of integrative health and cell-based technologies.

Today, Dr. Anton is based in the United States , where he operates a dedicated research laboratory focused on biotechnology innovation, formulation development, and product translation. His work has increasingly shifted from clinical practice to research-driven product development, including biotechnology-grade skincare formulations that leverage advanced cellular science.

As Head of Product Research & Development at Lavo Lab, Dr. Anton leads all scientific research, formulation strategy, and innovation pipelines. His leadership ensures that LAVO products are developed under strict biotechnology standards, with uncompromising commitments to safety, quality, regulatory integrity, and scientific rigor.

— JACKSON

Jackson serves as the Chief Strategy Officer (CSO) of the company, bringing over five years of extensive experience in the financial markets. He possesses a deep understanding of market dynamics, investment strategies, and risk management, and has a proven track record of guiding organizations in strategic planning, growth initiatives, and operational optimization.

In his role as CSO, Jackson is responsible for developing and executing the company’s long-term strategic vision, analyzing market trends, and identifying opportunities to enhance business performance and competitive positioning. He works closely with leadership teams toalign strategic objectives with operational execution, ensuring sustainable growth and resilience in a rapidly evolving market landscape.

Jackson’s expertise spans financial analysis, market forecasting, partnership development, and business expansion, making him a key driver in shaping the company’s overall growth trajectory and market strategy. His strategic insights and forward-looking approach help the company navigate complex markets, capitalize on emerging opportunities, and maintain a competitive edge.

— KEVIN

Kevin serves as Compliance and Regulatory Counsel at LAVO Protocol, where he oversees legal, compliance, and regulatory strategy across the protocol’s decentralized science (DeSci) and biotechnology initiatives.

With a strong focus on blockchain regulation, digital assets compliance, and cross-border legal frameworks, Kevin works closely with the core team to ensure LAVO’s ecosystem is built on a compliant, transparent, and sustainable foundation. His role includes advising on regulatory risk management, token design considerations, partnership structures, and alignment with evolving global compliance standards.

As LAVO Protocol bridges biotechnology, decentralized data ownership, and on-chain scientific assets, Kevin plays a critical role in navigating the complex intersection of life sciences regulation and Web3 governance, supporting responsible innovation while enabling scalable global expansion.